CollPlant Biotechnologies annual stock-based compensation
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Stock-Based Compensation Growth & History (CLGN)
CollPlant Biotechnologies's stock-based compensation was $999,000 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $999,000 | −$720,000 | −41.88% |
| 2024 | 2024-12-31 | $1.7M | −$218,000 | −11.25% |
| 2023 | 2023-12-31 | $1.9M | −$237,000 | −10.90% |
| 2022 | 2022-12-31 | $2.2M | $577,000 | +36.13% |
| 2021 | 2021-12-31 | $1.6M | −$77,000 | −4.60% |
| 2020 | 2020-12-31 | $1.7M | $549,000 | +48.80% |
| 2019 | 2019-12-31 | $1.1M | −$309,000 | −21.55% |
| 2018 | 2018-12-31 | $1.4M | $478,000 | +50.00% |
| 2017 | 2017-12-31 | $956,000 | — | — |
CollPlant Biotechnologies quarterly stock-based compensation
Q2.19
Q2.20
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $180,000 | −$202,000 | −52.88% |
| Q4 2025 | 2025-12-31 | −$18,000 | — | — |
| Q3 2025 | 2025-09-30 | $282,000 | — | — |
| Q2 2025 | 2025-06-30 | $356,000 | −$134,000 | −27.35% |
| Q1 2025 | 2025-03-31 | $382,000 | — | — |
| Q2 2024 | 2024-06-30 | $490,000 | $152,000 | +44.97% |
| Q2 2023 | 2023-06-30 | $338,000 | — | — |
| Q2 2020 | 2020-06-30 | $477,000 | $188,000 | +65.05% |
| Q2 2019 | 2019-06-30 | $289,000 | — | — |
CollPlant Biotechnologies stock-based compensation trends
Over the last five fiscal years, CollPlant Biotechnologies's stock-based compensation decreased from $1.7M to $999,000, a change of −$675,000. The latest reported quarter, Q1 2026, shows $180,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗